Home › Conditions › Tumour Lysis Syndrome (TLS)

Oncology

Tumour Lysis Syndrome (TLS)

Tumour lysis syndrome (TLS) results from rapid malignant cell death releasing intracellular contents. Adult Cairo-Bishop lab TLS: ≥2 different metabolic abnormalities within 3 days before to 7 days after treatment. Count urate ≥476 μmol/L, K+ ≥6 mmol/L, phosphate ≥1.45 mmol/L or Ca²⁺ ≤1.75 mmol/L; the same parameter can instead qualify by a ≥25% rise (urate/K/phosphate) or ≥25% fall (calcium). Clinical TLS adds creatinine ≥1.5× ULN, arrhythmia or seizure. High-risk tumours include Burkitt's lymphoma, ALL with high WBC. Venetoclax-treated CLL has low–high TLS risk, depending on tumour burden and patient factors.

BSH Tumour Lysis Syndrome Guideline

The pathway

Risk stratify before chemotherapy

IV hydration

Allopurinol for low/intermediate risk

Rasburicase for high risk or established TLS

Manage electrolyte abnormalities

Intensive monitoring

Haemodialysis indications

Drugs

DrugDoseRouteNotes
Allopurinol300mg ODPOLow/intermediate risk prophylaxis. Start 24–48h before chemotherapy. Renal impairment: e.g. 100mg OD; severe impairment may need <100mg/day or 100mg at longer intervals. Confirm with haematology/pharmacy.
Rasburicase0.2mg/kg ODIVHigh risk or established TLS. CONTRAINDICATED in G6PD deficiency — haemolytic anaemia risk. Keep uric acid sample on ice. Very unwell with delayed G6PD result: responsible consultant decides urgent treatment after individual risk–benefit review; never give in known G6PD deficiency. Stop allopurinol when rasburicase starts; it may restart 24 h after the last dose.
Calcium gluconate 10%30ml over 10 minIVMembrane stabilisation in hyperkalaemia with ECG changes. Does not lower serum K+.
Insulin (Actrapid) + Dextrose 50%10 units + 50mlIVShifts K+ intracellularly in 20–30 minutes. BM at 0, 30, 60, 90 and 120 minutes, then hourly to 6 hours. If pre-treatment BM <7.0, follow with 10% glucose 50ml/hr for 5 hours (UKKA 2026).
Sodium zirconium cyclosilicate10g TDS (up to 72h)OralRemoves K+ from body. Replaced calcium resonium in the UKKA 2023 emergency algorithm. Onset ~1h. Use alongside rapid-acting agents, never instead of them.

When to escalate

Reference: BSH Updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children (2025)

Practise and explore

Practise a case or explore differentials here on the website. The optional browser app adds personal learning tools and saved progress.

Ready for your next shift

Get it on your phone

Free, offline, no account.

Download bleep oncall

The current iPhone release, on the App Store.

Made between shifts

Keep bleep brewing.

Free to use. Ad-free by choice. If bleep has helped you through a shift, you can support what comes next.

Buy me a coffee

A small thank you. Always optional.